Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Taylor, Anna L., et al. - Recommended first-line treatment for posttransplant lymphoproliferative disorder (PTLD) is reduction in immunosuppressive therapy, irrespective of histopathological type...Conclusion: The use of anthracycline-based chemotherapy and reduction of immunosuppression as first-line treatment in adults with monomorphic PTLD is well tolerated and achieves sustained complete remission in around 70% of patients with a low risk of graft loss

Today in Hematology/Oncology...keeping you current

The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/04/09

IL-13 from Th2-type cells suppresses induction of antigen-specific Th1 immunity in a T-cell lymphoma
International Immunology, 12/03/09

Prioritization of cancer antigens: keeping the target in sight
Expert Review of Vaccines, 12/02/09

Today in Surgery/Transplantation...keeping you current

Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival
Nephrology Dialysis Transplantation, 12/04/09

Therapy with Nonglycosaminoglycan-Binding Mutant CCL7: A Novel Strategy to Limit Allograft Inflammation
American Journal of Transplantation, 12/03/09

Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft
International Immunology, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address